| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Baumer S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$11.24 |
| 52 Week High | R$12.30 |
| 52 Week Low | R$9.10 |
| Beta | 0.45 |
| 1 Month Change | 0.089% |
| 3 Month Change | -3.93% |
| 1 Year Change | n/a |
| 3 Year Change | -38.24% |
| 5 Year Change | 2.18% |
| Change since IPO | 348.70% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| BALM3 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | -6.3% | 0.5% | 0.9% |
| 1Y | n/a | -1.8% | 15.2% |
Return vs Industry: Insufficient data to determine how BALM3 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how BALM3 performed against the BR Market.
Price Volatility
| BALM3 volatility | |
|---|---|
| BALM3 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 8.9% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: BALM3 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BALM3's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | n/a | Ruy Salvari Baumer | www.baumer.com.br |
Baumer S.A. develops solutions for health industry in Brazil. It offers environment monitor, an electronic system that monitors particles suspended in air PM10 and PM2.5, which includes temperature, relative humidity, concentration of carbon dioxide and chemical pollutants, environmental noise intensity, lighting conditions, presence of people and animals, and relative pressure. The company also provides Purafog, a web and dry nebulization; PuraVac; mini purifies; and dental solutions, such as bone graft and membrane solutions.
Baumer S.A. Fundamentals Summary
| BALM3 fundamental statistics | |
|---|---|
| Market cap | R$106.31m |
| Earnings (TTM) | R$8.94m |
| Revenue (TTM) | R$169.95m |
11.5x
P/E Ratio0.6x
P/S RatioIs BALM3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BALM3 income statement (TTM) | |
|---|---|
| Revenue | R$169.95m |
| Cost of Revenue | R$67.07m |
| Gross Profit | R$102.88m |
| Other Expenses | R$93.94m |
| Earnings | R$8.94m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.91 |
| Gross Margin | 60.53% |
| Net Profit Margin | 5.26% |
| Debt/Equity Ratio | 13.9% |
How did BALM3 perform over the long term?
See historical performance and comparison